Search Login Register

Ranitidine (Zantac) Summary

Description: A non-imidazole blocker of those histamine receptors that mediate gastric secretion (H2 receptors). It is used to treat gastrointestinal ulcers.

Also Known As: Zantac; Ranitidin; AH-19065; Biotidin; N (2-(((5-((Dimethylamino)methyl)-2-furanyl)methyl)thio)ethyl)-N'-methyl-2-nitro-1,1-ethenediamine Show All >>

Networked: 2073 relevant articles (355 outcomes, 480 trials/studies) for this Drug

Key Diseases for which Ranitidine is Relevant

  1. Duodenal Ulcer (Curling's Ulcer) : 108 outcomes 163 studies in 576 results
  2. Ulcer : 68 outcomes 87 studies in 491 results
  3. Stomach Ulcer (Gastric Ulcer) : 47 outcomes 67 studies in 207 results
  4. Peptic Ulcer (Peptic Ulcers) : 28 outcomes 37 studies in 160 results
  5. Heartburn (Pyrosis) : 24 outcomes 20 studies in 85 results
Show All >>

Drugs Related to Ranitidine

  1. Omeprazole (Esomeprazole)
  2. Cimetidine (Biomet)
  3. Famotidine (Pepcid)
  4. pantoprazole (Protonix)
  5. Sucralfate (Carafate)
  6. lansoprazole (Prevacid)
  7. Histamine (Histamine Dihydrochloride)
  8. Misoprostol (Cytotec)
  9. Nizatidine (Axid)
  10. Ranitidine (Zantac)
Show All >>

Therapies Related to Ranitidine

  1. Aftercare (After-Treatment)
  2. Blood Transfusion (Blood Transfusions)
  3. Endoscopic Hemostasis
  4. Sclerotherapy
  5. Premedication
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.